6-bromo-2-chloro-7,8-dihydroquinolin-5(6H)-one | 124467-37-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 6-bromo-2-chloro-7,8-dihydroquinolin-5(6H)-one
• 英文别名: 2-chloro-6-bromo-7,8-dihydro-5-quinolinone；6-bromo-2-chloro-7,8-dihydro-6H-quinolin-5-one
• CAS: 124467-37-4
• 化学式: C₉H₇BrClNO
• 分子量: 260.518
• InChiKey: ZPULEELDGQLITG-UHFFFAOYSA-N

物化性质

• 沸点：
  370.5±42.0 °C(Predicted)
• 密度：
  1.710±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  30
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  6-bromo-2-chloro-7,8-dihydroquinolin-5(6H)-one 在 lithium chloride 作用下， 以 N-甲基乙酰胺 为溶剂， 生成 2-氯喹啉-5-醇
  参考文献：
  名称：

  Pesticides

  摘要：

  公式（I）的化合物ArQQ.sup.1 C(.dbd.X)NHR.sup.1（I）或其盐已被披露，其中Ar是一个含有n个环的可选择取代的多环环系，其中n是整数2或3，至少n-1个环是芳香的，含有一个到三个环氮原子，且可选择地含有一个或多个额外的杂原子；Q是一个含有1到12个碳原子的烷基链，可选择地含有一个硫或一个或两个氧原子；Q.sup.1是一个基团（C(R.sup.2).dbd.C(R.sup.3)).sub.a--(C(R.sup.4).dbd.C(R.sup.5))，其中a为0或1，R.sup.2，R.sup.3，R.sup.4和R.sup.5相同或不同，至少两个是氢，另外两个独立地选择自氢、卤素、C.sub.1-4卤代烷基；X是氧或硫；R.sup.1选择自氢和C.sub.1-8烃基，可选择地经二氧杂环戊二烯基、卤素、氰基、三氟甲基、三氟甲硫基或C.sub.1-6烷氧基取代的烃基所述，具有特别对节肢动物害虫具有活性。还披露了含有公式（1）的化合物的杀虫剂配方、它们在害虫控制中的使用以及它们的制备方法。

  公开号：

  US05114940A1
• 作为产物：
  描述：

  2-氯-7,8-二氢-6H-喹啉-5-酮 在 氢溴酸 、 溴 作用下， 以 二氯甲烷 为溶剂， 以64%的产率得到6-bromo-2-chloro-7,8-dihydroquinolin-5(6H)-one
  参考文献：
  名称：

  [EN] SUBSTITUTED TETRAHYDROQUINOLINONE COMPOUNDS AS ROR GAMMA MODULATORS
  [FR] COMPOSÉS TÉTRAHYDROQUINOLINONE SUBSTITUÉS EN TANT QUE MODULATEURS DE ROR GAMMA

  摘要：

  本发明提供了公式（I）的取代四氢喹啉酮及相关化合物，作为视黄酸受体相关孤儿受体（RORs）的调节剂，在RORγ调节剂方面具有治疗上的用途。这些化合物在治疗和预防疾病和/或紊乱方面具有用途，特别是它们在由RORγ受体介导的疾病和/或紊乱中的用途。本发明还提供了这些化合物的制备以及包含至少一种取代四氢喹啉酮或相关化合物的制剂和药物配方，以及其所用的药学上可接受的载体、稀释剂或赋形剂。

  公开号：

  WO2016185342A1

文献信息

• Heteroaromatic enamide derivatives and their use as pesticides
  申请人：ROUSSEL UCLAF

  公开号：EP0317188A2

  公开（公告）日：1989-05-24

  Compound Of the formula (I) are disclosed or a salt thereof, wherein Ar is an optionally substituted polycyclic ring system containing n rings, where n is the integer 2 or 3, at least n-1 rings being aromatic and containing one to three ring nitrogen atoms and optionally containing one or more additional heteroatoms; Q is an alkyl chain containing 1 to 12 carbon atoms and optionally containing a sulphur or one or two oxygen atoms; Q1 is a group (C(R2)=C(R3))a-(C(R4)=(C(R5)) wherein a is 0 or 1, R2, R3, R4- and R5 are the same or different, at least two being hydrogen and the other two being independently selected from hydrogen, halo, C1-4 haloalkyl; X is oxygen or sulphur; and R1 is selected from hydrogen and C1-8 hydrocarbyl optionally substituted by dixalanyl, halo, cyano, trifluoromethyl, trifluoromethylthio or C1-6 alkoxy are described which have activity particularly against arthropod pests. Pesticidal formulations containing the compounds of the formula (1), their use in the control of pests and method for their preparation are also disclosed.

  公开了式 (I) 化合物 或其盐，其中 Ar 是含有 n 个环的任选取代的多环环系，其中 n 是整数 2 或 3，至少 n-1 个环是芳香族环，含有 1 至 3 个环氮原子，并任选含有一个或多个额外的杂原子；Q 是含有 1 至 12 个碳原子的烷基链，并任选含有一个硫原子或一个或两个氧原子；Q1是一个基团(C(R2)=C(R3))a-(C(R4)=(C(R5))，其中a是0或1，R2、R3、R4-和R5相同或不同，至少两个是氢，另外两个独立地选自氢、卤素、C1-4卤代烷基；X是氧或硫；和 R1 选自氢和任选被二硅烷基、卤代、氰基、三氟甲基、三氟甲硫基或 C1-6 烷氧基取代的 C1-8 碳氢基。还公开了含有式（1）化合物的杀虫制剂、其在防治害虫中的用途及其制备方法。
• METHOD FOR THE PREPARATION OF TETRAHYDROQUINOLINONE COMPOUNDS HAVING ROR-GAMMA MODULATING ACTIVITY
  申请人：Aurigene Discovery Technologies Limited

  公开号：EP3845526A1

  公开（公告）日：2021-07-07

  The present invention provides substituted tetrahydroquinolinone and related compounds of formula (I), which are therapeutically useful as modulators of Retinoic acid receptor-related orphan receptors (RORs), more particularly as RORy modulators. These compounds are useful in the treatment and prevention of diseases and/or disorder, in particular their use in diseases and/or disorder mediated by RORγ receptor. The present invention also provides preparation of the compounds and pharmaceutical formulations comprising at least one of the substituted tetrahydroquinolinone or related compounds of formula (I), together with a pharmaceutically acceptable carrier, diluent or excipient therefor.

  本发明提供了取代的四氢喹啉酮和相关的式(I)化合物，它们作为视黄酸受体相关孤儿受体（RORs）的调节剂，特别是作为RORy调节剂，具有治疗作用。这些化合物可用于治疗和预防疾病和/或失调，特别是用于 RORγ 受体介导的疾病和/或失调。本发明还提供了包含至少一种取代的四氢喹啉酮或式（I）相关化合物的化合物和药物制剂的制备方法，以及药学上可接受的载体、稀释剂或赋形剂。
• Substituted tetrahydroquinolinone compounds as ROR gamma modulators
  申请人：Aurigene Discovery Technologies Limited

  公开号：US11229636B2

  公开（公告）日：2022-01-25

  The present invention provides substituted tetrahydroquinolinone and related compounds of formula (I), which are therapeutically useful as modulators of Retinoic acid receptor-related orphan receptors (RORs), more particularly as RORγ modulators. These compounds are useful in the treatment and prevention of diseases and/or disorder, in particular their use in diseases and/or disorder mediated by RORγ receptor. The present invention also provides preparation of the compounds and pharmaceutical formulations comprising at least one of the substituted tetrahydroquinolinone or related compounds of formula (I), together with a pharmaceutically acceptable carrier, diluent or excipient therefor.

  本发明提供了取代的四氢喹啉酮和相关的式(I)化合物，它们作为视黄酸受体相关孤儿受体（RORs）的调节剂，特别是作为RORγ调节剂，具有治疗作用。这些化合物可用于治疗和预防疾病和/或紊乱，特别是用于治疗由 RORγ 受体介导的疾病和/或紊乱。本发明还提供了包含至少一种取代的四氢喹啉酮或式（I）相关化合物的化合物和药物制剂的制备方法，以及药学上可接受的载体、稀释剂或赋形剂。
• SUBSTITUTED TETRAHYDROQUINOLINONE COMPOUNDS AS ROR GAMMA MODULATORS
  申请人：Aurigene Discovery Technologies Limited

  公开号：EP3294713A1

  公开（公告）日：2018-03-21
• Substituted Tetrahydroquinolinone Compounds as ROR Gamma Modulators
  申请人：Aurigene Discovery Technologies Limited

  公开号：US20180200247A1

  公开（公告）日：2018-07-19

  The present invention provides substituted tetrahydroquinolinone and related compounds of formula (I), which are therapeutically useful as modulators of Retinoic acid receptor-related orphan receptors (RORs), more particularly as RORγ modulators. These compounds are useful in the treatment and prevention of diseases and/or disorder, in particular their use in diseases and/or disorder mediated by RORγ receptor. The present invention also provides preparation of the compounds and pharmaceutical formulations comprising at least one of the substituted tetrahydroquinolinone or related compounds of formula (I), together with a pharmaceutically acceptable carrier, diluent or excipient therefor.